Nexentis Technologies Inc.

NXTS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 3, 2026 8-K
10-Q Aug 13, 2026 10-Q
8-K Aug 6, 2026 8-K
EFFECT Jul 17, 2026
EFFECT Jul 15, 2026
SCHEDULE 13G/A Jul 15, 2026
S-1 Jul 13, 2026 S-1
POS AM Jul 13, 2026 POS AM
424B5 Jun 23, 2026 424B5
8-K Jun 22, 2026 8-K
424B5 Jun 15, 2026 424B5
8-K Jun 12, 2026 8-K
8-K May 27, 2026 8-K
10-Q May 14, 2026 10-Q
8-K Apr 30, 2026 8-K
EFFECT Apr 29, 2026
CORRESP Apr 28, 2026
UPLOAD Apr 27, 2026
S-3 Apr 16, 2026 S-3
8-K Apr 6, 2026 8-K
10-K Mar 31, 2026 10-K
4 Mar 26, 2026 FORM 4
3 Mar 23, 2026 FORM 3
SCHEDULE 13G Mar 23, 2026
8-K Mar 17, 2026 8-K
← Newer Page 1 of 12 · 296 filings Older →